BRAINSTORM CELL THERAPEUTICS INC. Quarterly Depreciation in USD from Q1 2016 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Brainstorm Cell Therapeutics Inc. quarterly/annual Depreciation history and growth rate from Q1 2016 to Q3 2024.
  • Brainstorm Cell Therapeutics Inc. Depreciation for the quarter ending September 30, 2024 was $59K, a 9.23% decline year-over-year.
  • Brainstorm Cell Therapeutics Inc. Depreciation for the twelve months ending September 30, 2024 was $253K, a 5.95% decline year-over-year.
  • Brainstorm Cell Therapeutics Inc. annual Depreciation for 2023 was $265K, a 7.02% decline from 2022.
  • Brainstorm Cell Therapeutics Inc. annual Depreciation for 2022 was $285K, a 9.62% increase from 2021.
  • Brainstorm Cell Therapeutics Inc. annual Depreciation for 2021 was $260K, a 18.7% increase from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $253K $59K -$6K -9.23% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 $259K $64K -$3K -4.48% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $262K $64K -$3K -4.48% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $265K $66K -$4K -5.71% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-01
Q3 2023 $269K $65K -$5K -7.14% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 $274K $67K -$4K -5.63% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 $278K $67K -$7K -9.46% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 $285K $70K $0 0% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-01
Q3 2022 $285K $70K +$3K +4.48% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $282K $71K +$9K +14.5% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $273K $74K +$13K +21.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 $260K $70K +$6K +9.38% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-30
Q3 2021 $254K $67K +$11K +19.6% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $243K $62K +$12K +24% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 $231K $61K +$12K +24.5% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 $219K $64K +$14K +28% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-28
Q3 2020 $205K $56K +$19K +51.4% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 $186K $50K +$17K +51.5% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $169K $49K +$5K +11.4% Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-26
Q4 2019 $164K $50K +$29K +138% Oct 1, 2019 Dec 31, 2019 10-K 2021-02-04
Q3 2019 $135K $37K +$4K +12.1% Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-15
Q2 2019 $131K $33K +$2K +6.45% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-05
Q1 2019 $129K $44K +$19K +76% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 $110K $21K -$7K -25% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-18
Q3 2018 $117K $33K +$10K +43.5% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 $107K $31K +$13K +72.2% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-13
Q1 2018 $94K $25K +$9K +56.3% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 $85K $28K +$6K +27.3% Oct 1, 2017 Dec 31, 2017 10-K/A 2019-04-01
Q3 2017 $79K $23K +$6K +35.3% Jul 1, 2017 Sep 30, 2017 10-Q 2018-10-29
Q2 2017 $73K $18K -$4K -18.2% Apr 1, 2017 Jun 30, 2017 10-Q 2018-07-23
Q1 2017 $77K $16K $0 0% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-14
Q4 2016 $77K $22K Oct 1, 2016 Dec 31, 2016 10-K 2018-03-08
Q3 2016 $17K Jul 1, 2016 Sep 30, 2016 10-Q 2017-10-17
Q2 2016 $22K Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-14
Q1 2016 $16K Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.